A Georgia resident recently filed a lawsuit against the manufacturers of Xarelto in the U.S. District Court for the Eastern District of Louisiana claiming that the blood thinner caused him to experience uncontrollable brain bleeding. The plaintiff began taking Xarelto in 2013 to treat atrial fibrillation, a common heart rhythm problem. However, the plaintiff alleges that the blood thinner caused him to suffer uncontrollable brain bleeding and develop life-long permanent injuries.
This lawsuit is one of approximately 2,500 filed against Xarelto’s manufacturers, Bayer HealthCare and Johnson & Johnson, alleging that the companies failed to warn patients and doctors about the risks associated with the blood thinner and the lack of an antidote to stop the bleeding. The Xarelto litigation is consolidated in the Eastern District of Louisiana as part of a multidistrict litigation (“MDL”) that commenced in December 2014. Many of those plaintiffs are represented by plaintiffs’ firm Grant & Eisenhofer, involved in the Bellwether Selection Committee and co-leading the Law & Briefing Committee of the Xarelto MDL. If you or a loved one experienced complications from taking the drug Xarelto, please call us at 888-207-0382 for a confidential evaluation of your potential claim.